Citadel Advisors
IMA

Citadel Advisors’s ImageneBio Inc IMA Stock Holding History

Citadel Advisors’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328K Sell
55,610
-68,735
-55% -$388K ﹤0.01% 10924
2026
Q1 		$622K Buy
124,345
+37,867
+44% +$246K ﹤0.01% 8761
2025
Q4 		$597K Sell
86,478
-35,769
-29% -$265K ﹤0.01% 8606
2025
Q3 		$996K Buy
122,247
+109,062
+827% +$1.45M ﹤0.01% 7539
2025
Q2 		$212K Buy
13,185
+6,544
+99% +$96.1K ﹤0.01% 10552
2025
Q1 		$102K Sell
6,641
-56
-0.8% -$966 ﹤0.01% 11427
2024
Q4 		$132K Sell
6,697
-7,054
-51% -$143K ﹤0.01% 11076
2024
Q3 		$285K Sell
13,751
-6,640
-33% -$134K ﹤0.01% 9438
2024
Q2 		$404K Buy
20,391
+7,140
+54% +$126K ﹤0.01% 8497
2024
Q1 		$226K Sell
13,251
-1,597
-11% -$29.1K ﹤0.01% 10078
2023
Q4 		$351K Sell
14,848
-2,380
-14% -$77.6K ﹤0.01% 8829
2023
Q3 		$895K Buy
17,228
+14,051
+442% +$846K ﹤0.01% 6816
2023
Q2 		$250K Sell
3,177
-11,831
-79% -$848K ﹤0.01% 9406
2023
Q1 		$621K Sell
15,008
-164,587
-92% -$7.56M ﹤0.01% 7860
2022
Q4 		$5.73M Sell
179,595
-278
-0.2% -$8.88K ﹤0.01% 3628
2022
Q3 		$7.66M Buy
179,873
+2,673
+2% +$155K ﹤0.01% 3156
2022
Q2 		$9.42M Sell
177,200
-75
-0% -$4.14K ﹤0.01% 2765
2022
Q1 		$13M Sell
177,275
-71
-0% -$7.55K ﹤0.01% 2558
2021
Q4 		$26.7M Buy
177,346
+89
+0.1% +$14.4K 0.01% 1715
2021
Q3 		$26.8M Sell
177,257
-2,461
-1% -$358K 0.01% 1669
2021
Q2 		$29.5M Buy
179,718
+8,629
+5% +$1.9M 0.01% 1632
2021
Q1 		$58M Buy
+171,089
New +$58.6M 0.01% 933

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Citadel Advisors's IMA Position: Q2 2026 in Review

Citadel Advisors reduced its ImageneBio Inc (IMA) stake by 55% in Q2 2026, selling an estimated $388K and leaving 55,610 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #10924.

Citadel Advisors first reported a position in IMA in Q1 2021 and has held it in 22 quarters since. The position peaked at $58M in Q1 2021. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Citadel Advisors held 55,610 shares of ImageneBio Inc worth $328K as of Q2 2026.
  • Citadel Advisors sold 68,735 ImageneBio Inc shares in Q2 2026, an estimated $388K.
  • ImageneBio Inc made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #10924 holding.
  • Citadel Advisors first reported a position in ImageneBio Inc in Q1 2021 and has held it in 22 quarters since.
  • Citadel Advisors's ImageneBio Inc position peaked at $58M in Q1 2021.
  • 35 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.